Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C

被引：0
|
作者：
Assmar, Mehdi [1 ]
Yeganeh, Sara [1 ]
Mansourghanaei, Fariborz [2 ]
Amirmozafari, Nour [3 ]
机构：
[1] Islamic Azad Univ, Dept Microbiol, Lahijan, Iran
[2] Guilan Univ Med Sci, Gastrointestinal & Liver Dis Res Ctr, Rasht, Iran
[3] Iran Univ Med Sci, Sch Med, Dept Microbiol, Tehran, Iran
来源：
IRANIAN JOURNAL OF PUBLIC HEALTH | 2016年 / 45卷 / 12期
关键词：
Tumor markers; Hepatitis B; Hepatitis C; ELISA; CLINICAL-IMPLICATIONS; ALPHA-FETOPROTEIN; LIVER-DISEASE; SERUM; CANCER; EPIDEMIOLOGY; PREVALENCE; INFECTION; ANTIGEN;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Background: This study aimed to determine the role of tumor markers AFP, CA15-3, CA125, CA19-9 and CEA in patients with hepatitis B and C. Methods: This descriptive cross-sectional study was performed from Oct 2012 to Oct 2014. Serum samples of 129 patients with hepatitis B and C referred to Guilan Liver and Digestive Disease Research Center in Rasht, Iran were collected and checked for the existence of the listed tumor markers by ELISA. Results: No increase in serum levels of tumor marker CA19-9, CEA and CA15-3 were seen in patients with hepatitis (P>0.05). In patients with hepatitis B, increase in CA125 were observed (P=0.03). In hepatitis C patients, there was an increase in AFP levels (P=0.03). Conclusion: The levels of AFP and CA125 markers were high in hepatitis C and hepatitis B, respectively. However, the increased levels were not seen is malignancy. Due to the small sample size, further study is necessary to find the reasons of the increase.
引用
收藏
页码：1645 / 1651
页数：7
相关论文
共 50 条
  • [11] Combined use of AFP, CEA, CA125 and CA19-9 improves the sensitivity for the diagnosis of gastric cancer
    He, Chao-Zhu
    Zhang, Kun-He
    Li, Qing
    Liu, Xiao-Hua
    Hong, Yan
    Lv, Nong-Hua
    BMC GASTROENTEROLOGY, 2013, 13
  • [12] BETWEEN-LAB AGREEMENT FOR THE TUMOR-MARKERS TPA, CA19-9, CA125, CA15-3 OBSERVED IN A MULTICENTER STUDY
    PILO, A
    ZUCCHELLI, GC
    CHIESA, MR
    MASINI, S
    CLINICAL CHEMISTRY, 1988, 34 (06) : 1298 - 1299
  • [13] EVALUATION OF TUMOR-MARKERS CA19-9, CA125 AND CEA IN PANCREATIC-CANCER AND OTHER DISEASES
    ZHANG, HY
    BRITISH JOURNAL OF CANCER, 1987, 56 (04) : 522 - 522
  • [14] 探讨肿瘤标记物CEA、CA15-3、CA19-9、CA125及AFP在胸腔积液中的诊断价值
    沈菁
    徐如梅
    吴绍莲
    韦常宏
    实验与检验医学, 2009, 27 (01) : 39 - 41
  • [15] A Panel of CA19-9, Ca125, and Ca15-3 as the Enhanced Test for the Differential Diagnosis of the Pancreatic Lesion
    Hogendorf, Piotr
    Skulimowski, Aleksander
    Durczynski, Adam
    Kumor, Anna
    Poznanska, Grahyna
    Olesna, Aleksandra
    Rut, Joanna
    Strzelczyk, Janusz
    DISEASE MARKERS, 2017, 2017
  • [16] Diagnostic value of serum CA125, CA19-9 and CA15-3 in endometriosis: A meta-analysis
    Shen, Airong
    Xu, Shengnan
    Ma, Yange
    Guo, Huanhuan
    Li, Canyu
    Yang, Chunli
    Zou, Shunhong
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2015, 43 (05) : 599 - 609
  • [17] CA15-3, CA125 and CA19-9 assay evaluation on advia centaur and architect i2000SR
    Paola, Bellati
    Montanelli, A.
    Grassini, A.
    Arsola, L.
    TUMOR BIOLOGY, 2006, 27 : 89 - 89
  • [18] 血清CA15-3、CA125、CA19-9、CEA联检在乳腺癌中的诊断价值
    顾晓东
    黄海龙
    放射免疫学杂志, 2011, 24 (01) : 85 - 86
  • [19] Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer
    Feng, Fan
    Tian, Yangzi
    Xu, Guanghui
    Liu, Zhen
    Liu, Shushang
    Zheng, Gaozan
    Guo, Man
    Lian, Xiao
    Fan, Daiming
    Zhang, Hongwei
    BMC CANCER, 2017, 17
  • [20] 大肠癌患者肿瘤标志物CA19-9、CEA、CA242、AFP、CA125和CA15-3检测结果分析
    张海林
    贾爱萍
    邢丽
    微循环学杂志, 2013, 23 (03) : 11 - 12+79
12345